Detalhe da pesquisa
1.
A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin.
Gastroenterology
; 139(5): 1593-601, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20637202
2.
Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirin.
Liver Int
; 28(1): 61-71, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17971091
3.
Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C.
Pharmacoeconomics
; 21(5): 341-9, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12627987